2011
DOI: 10.1016/j.mrfmmm.2011.01.001
|View full text |Cite
|
Sign up to set email alerts
|

XRCC1 and ERCC1 variants modify malignant mesothelioma risk: A case–control study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
40
1

Year Published

2014
2014
2016
2016

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 37 publications
(42 citation statements)
references
References 62 publications
1
40
1
Order By: Relevance
“…In another perspective, it could be due to higher rates of ERCC1 release in order to correct metaplasia caused by smoking (Pfeifer et al, 2002). In a study on MPM patients by Betti et al, it was reported that ERCC1 enzyme is increased due to mutations caused by asbestos exposure (Betti et al, 2011). In our study, it was found that 61.7% of ERCC1-negative and 42.1% of ERCC1-positive patients were survived among the patients received cisplatin-based chemotherapy.…”
Section: Discussionmentioning
confidence: 52%
See 1 more Smart Citation
“…In another perspective, it could be due to higher rates of ERCC1 release in order to correct metaplasia caused by smoking (Pfeifer et al, 2002). In a study on MPM patients by Betti et al, it was reported that ERCC1 enzyme is increased due to mutations caused by asbestos exposure (Betti et al, 2011). In our study, it was found that 61.7% of ERCC1-negative and 42.1% of ERCC1-positive patients were survived among the patients received cisplatin-based chemotherapy.…”
Section: Discussionmentioning
confidence: 52%
“…The primary function of ERCC1 is nucleotide excision repair of damaged DNA. There are strong evidence coming from preclinical and clinical trials, indicating that ERCC1 has an independent predictive value regarding prognosis, response to treatment, recurrence and overall survival (Olaussen et al, 2006;Ozkan et al, 2010;Betti et al, 2011; Zhang et al, 2012; Zhang et al, 2013; Li et al, 2013; Li XD et al, 2013; Mechanicsville 2013). Although there are studies on ERCC1 expression level and effects of chemotherapy on survival in MPM from several countries, this is a relatively new topic with conclusions covering small groups (Martin et al, 2008;Righi et al, 2010; Zimling et al, 2012).…”
mentioning
confidence: 99%
“…SNPs are the most frequent type of polymorphisms in humans, accounting for approximately 90% of them (140). SNP identification is possible from different human samples, and venous blood is the tissue sample of choice; however, specific blood cell populations are used, for example leukocytes (141,142), lymphocytes (143)(144)(145) and the mononuclear fraction (146), and tissues such as placenta (20), or even buccal cells (147,148) are also appropriate for genotyping. Several methods have been developed for their identification, with DNA sequencing being the gold standard (149).…”
Section: Genetic Polymorphismsmentioning
confidence: 99%
“…The most common method for SNP analysis uses restriction endonucleases in cases where the polymorphism creates or destroys a specific nucleotide recognition sequence for a restriction enzyme (restriction fragment length polymorphism or RFLP). Other useful methods are real-time PCR using TaqMan probes (13,148,150), and primer extension-based methods (145,151,152) (table 3).…”
Section: Genetic Polymorphismsmentioning
confidence: 99%
See 1 more Smart Citation